Opportunity Information:

  • The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395.
  • This funding opportunity was created on Sep 23, 2019.
  • Applicants must submit their applications by Nov 13, 2019.
  • Each selected applicant is eligible to receive up to $3,300,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Public and State controlled institutions of higher education.
Apply for RFA CA 19 059
Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: White Earth Fire Management Cooperative Agreement

Previous opportunity: Nanoscale Interactions

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 19 059

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 19 059) also looked into and applied for these:

Funding Number Funding Title
RFA DA 20 027 Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
RFA CA 20 002 Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network (NCTN)(U24 Clinical Trial Not Allowed)
RFA CA 20 006 Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional)
RFA CA 20 017 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
RFA CA 20 020 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
RFA CA 20 019 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
RFA CA 20 018 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
RFA CA 20 007 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
RFA CA 20 009 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
RFA CA 20 010 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
RFA CA 20 011 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
RFA CA 20 012 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
RFA CA 20 013 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
72ASHA18RFA00001 FY 2018 American Schools and Hospitals Abroad (ASHA) Program
RFA CA 20 030 Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)
RFA CA 20 031 Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
RFA CA 20 029 Metastasis Research Network (U54 Clinical Trial Not Allowed)
RFA CA 20 035 Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
RFA CA 20 036 Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
RFA OD 20 018 Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 059", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: